Izotropic Corporation

3/25/2025

Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication

VIEW

3/10/2025

Izotropic to Present at Investor Conference March 13th

VIEW

2/19/2025

FDA Sets Meeting Date with Izotropic

VIEW

2/14/2025

Izotropic Closes Non-Brokered Private Placement

VIEW

2/7/2025

Izotropic Announces Non-Brokered Private Placement- February 2025

VIEW

2/6/2025

Izotropic Reschedules Investor Conference Presentation to March 13th

VIEW

2/3/2025

Izotropic to Present at Investor Conference February 6th

VIEW

1/29/2025

Izotropic Announces Timelines and Milestones to IzoView Product Launch

VIEW

1/17/2025

Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast

VIEW

1/15/2025

Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions

VIEW

1/9/2025

Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening

VIEW

12/31/2024

Izotropic Announces AGM Results - 2024

VIEW

12/4/2024

Izotropic Provides Update On Annual General Meeting Materials and Voting Procedures

VIEW

11/13/2024

Izotropic Corporation Announces Non-Brokered Private Placement- November 2024

VIEW

8/23/2024

Izotropic Announces Regulatory Approval Plans to Launch IzoView for Breast Cancer Diagnostics in Patients with Dense Breasts in the U.S. and EU

VIEW

7/17/2024

Izotropic Amends Promissory Note Agreement With Primary Lender

VIEW

6/14/2024

Izotropic Announces Closing of First Tranche of Non-Brokered Private Placement

VIEW

6/6/2024

Izotropic Corporation Announces Non-Brokered Private Placement- June 2024

VIEW

1/30/2024

Izotropic Receives Response From U.S. FDA

VIEW

1/8/2024

Izotropic Provides Regulatory and Operational Updates

VIEW

12/22/2023

Izotropic Announces AGM Results- 2023

VIEW

11/1/2023

Izotropic Completes Pre-Submission Meeting With U.S. FDA

VIEW

9/27/2023

Izotropic Confirms FDA Pre-Submission Meeting Date

VIEW

9/20/2023

Izotropic Closes Non-Brokered Private Placement- September 2023

VIEW

9/13/2023

Izotropic Corporation Announces Non-Brokered Private Placement- September 2023

VIEW

9/6/2023

Izotropic Files Class II Pre-Submission with FDA & Releases Details On Predicate Devices

VIEW

6/27/2023

Izotropic Engages Market Awareness Consultant

VIEW

6/20/2023

Izotropic Modifies Market Approval Pathway & Strategy

VIEW

6/8/2023

Izotropic CEO Resigns

VIEW

5/15/2023

Izotropic Completes QSUB Meeting with FDA Regarding Clinical Study Acceleration

VIEW

4/27/2023

Izotropic Provides Business Update

VIEW

3/29/2023

Izotropic to Extend Period for Unsecured Loans

VIEW

2/23/2023

Izotropic’s Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology

VIEW

1/13/2023

Izotropic’s IzoView Breast CT Device To Be Featured On Advancements TV Show In USA

VIEW

1/12/2023

Izotropic Creates Compensation Committee and Adopts Charter

VIEW

1/9/2023

Izotropic Releases First Video of IzoView

VIEW

1/4/2023

Izotropic Reports Board Meeting Results

VIEW

News